scholarly journals Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report

2018 ◽  
Vol 19 (1) ◽  
Author(s):  
Vassilios Liakopoulos ◽  
Panagiotis I Georgianos ◽  
Paraskevi Demirtzi ◽  
Vasilios Vaios ◽  
Theofanis Kalathas ◽  
...  
Keyword(s):  
2013 ◽  
Vol 68 (3) ◽  
pp. 232-233 ◽  
Author(s):  
V Gérard ◽  
E Delgrange ◽  
C de Halleux ◽  
D Vanpee

2020 ◽  
Author(s):  
Alice Serafini ◽  
Peter K. Kurotschka ◽  
Mariabeatrice Bertolani ◽  
Silvia Riccomi

Abstract Background: the most commonly reported clinical manifestations of Coronavirus Disease (COVID- 19) are: fever, fatigue, dry cough, anorexia, myalgias, dyspnoea and sputum production. Other, rarer, manifestations include headache, sore throat, rhinorrhoea, nausea, diarrhoea and olfactory or taste disorders. Two recent small-scale studies suggest the possibility of a skin rash being a clinical presentation of the disease. The purpose of our case report is to bring attention to an atypical presentation of the disease (skin rash) and reflect on the importance of the correct identification of COVID-19 suspicious symptoms as part of the crucial activity of case-finding in primary care.Case presentation: the patient is an Italian 32 years old female nurse who has had several close contacts to COVID-19 cases during her working shifts. On the 13 th March 2020 she developed an itchy erythematous papular rash sparing only her sparing only her face, scalp and abdomen. One week later she developed fever and diarrhoea. During the first week of remote assessment carried out by her General Practitioner (GP), she gradually developed a dry cough, intermittent fever and diarrhoea. At the time of article submission (31 days after the symptoms onset), she has not completely recovered and is still suffering of a dry cough, headache, fatigue and, occasionally, diarrhoea.Conclusions: this study suggest that skin manifestations could be an early presentation of COVID-19 and, during outbreaks, they should be taken into proper account by primary care providers as possibly caused by Sars-Cov-2. Early identification of COVID-19 patients is a crucial part of the strategy of case detection and case isolation, which has shown to be crucial in the reduction of incidence and COVID-19-related mortality. Further research is needed to establish frequency, symptoms, signs, pathogenesis and role in case detection of skin manifestations in COVID-19 patients.


2007 ◽  
Vol 27 (4) ◽  
pp. 391-394 ◽  
Author(s):  
Kim C.E. Sigaloff ◽  
Carola W.H. de Fijter

Neurological complications of varicella zoster virus (VZV) reactivation have rarely been described in dialysis patients. We report a case of a continuous ambulatory peritoneal dialysis (CAPD) patient who developed herpes zoster encephalitis. The patient was treated with acyclovir and steroids and had a slow but complete return to her prior cognitive status. The available literature is reviewed and the differential diagnosis with acyclovir toxicity is discussed.


2020 ◽  
Vol 14 (1) ◽  
Author(s):  
Alice Serafini ◽  
Peter Konstantin Kurotschka ◽  
Mariabeatrice Bertolani ◽  
Silvia Riccomi

Abstract Background Several recent studies suggest the possibility of a skin rash being a clinical presentation of coronavirus disease 2019 (COVID-19). The purpose of this case report is to bring attention to skin manifestations in the early stage of COVID-19 in order to support frontline physicians in their crucial activity of case identification. Case presentation The patient is an Italian 32-year-old female nurse who had several close contacts with multiple patients with COVID-19 as part of her professional workload. On March 13, 2020, the patient developed an itchy, erythematous papular rash (sparing only her face, scalp, and abdomen), which lasted for 10 days. The rash was accompanied by a feeling of general fatigue that gradually worsened over the following days and has continued for 5 months (until the end of July 2020). During the first week of remote assessment carried out by her general practitioner, the patient gradually developed a dry cough, intermittent fever, and diarrhoea and then had a positive test result for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Her skin manifestations disappeared completely 48 days after the onset of the disease, followed by the disappearance of the dry cough. Conclusions In light of recent studies, this case report suggests that skin manifestations, when taken into account with other situational factors (such as profession and patient history) should be taken into proper consideration by frontline physicians as possibly being caused by SARS-CoV-2. Early identification of COVID-19 is a key part of the strategy of case detection and case isolation. To enhance this activity, further research is needed to establish frequency, symptoms, signs, and pathogenesis of skin manifestations in patients with COVID-19.


2014 ◽  
Vol 14 (S3) ◽  
Author(s):  
Gopalakrishnan Sathya Narayanan ◽  
Radha Vijayaraghavan ◽  
Thangam Menon

Lung Cancer ◽  
2016 ◽  
Vol 99 ◽  
pp. 66-68 ◽  
Author(s):  
Masayuki Shirasawa ◽  
Masaru Kubota ◽  
Shinya Harada ◽  
Hideyuki Niwa ◽  
Seiichiro Kusuhara ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-3 ◽  
Author(s):  
Ashraf Al-Faouri ◽  
Khaled Ajarma ◽  
Samer Alghazawi ◽  
Sura Al-Rawabdeh ◽  
Adnan Zayadeen

The rarity of glucagonoma imposes a challenge with most patients being diagnosed after a long period of treatment for their skin rash (months-years). Awareness of physicians and dermatologists of the characteristic necrolytic migratory erythema often leads to early diagnosis. Early diagnosis of glucagonoma even in the presence of resectable liver metastases may allow curative resection. Herein, we present a typical case of glucagonoma treated at our center and review the literature pertinent to its management.


Sign in / Sign up

Export Citation Format

Share Document